Cargando…

The effect of feedback on cardiovascular risk factors on optimization of primary prevention: The PharmLines initiative

BACKGROUND: It is unknown whether population based single assessment of cardiovascular disease (CVD) risk and feedback to individuals and general practitioners results in initiation of preventive cardiovascular pharmacotherapy in those at risk. METHODS: The population based cohort study Lifelines wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Ende, M. Yldau, Waardenburg, Ingmar E., Lipsic, E., Bos, Jens H.J., Hak, Eelko, Snieder, H., Harst, Pim van der
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803074/ https://www.ncbi.nlm.nih.gov/pubmed/33447768 http://dx.doi.org/10.1016/j.ijchy.2020.100042

Ejemplares similares

Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative
por: Hunt, Nicholas B., et al.
Publicado: (2022)

Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study
por: Steenhuis, Dennis, et al.
Publicado: (2022)

Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative
por: Sediq, Rahmat, et al.
Publicado: (2018)

Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020)

Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study
por: HAISMA, Marjolijn S., et al.
Publicado: (2023)

The Groningen electrocardiographic criteria for left ventricular hypertrophy: a sex-specific analysis
por: van der Ende, M. Yldau, et al.
Publicado: (2021)

Sex‐Based Differences in Unrecognized Myocardial Infarction
por: van der Ende, M. Yldau, et al.
Publicado: (2020)

Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020)

Commentary on: “Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study”
por: BRIGHT, Heber Rew, et al.
Publicado: (2023)

Causal Pathways from Blood Pressure to Larger QRS Amplitudes: a Mendelian Randomization Study
por: Van Der Ende, M. Yldau, et al.
Publicado: (2018)

Author Correction: Causal Pathways from Blood Pressure to Larger QRS Amplitudes: a Mendelian Randomization Study
por: Van Der Ende, M. Yldau, et al.
Publicado: (2018)

Predictors of left ventricular remodeling after ST-elevation myocardial infarction
por: Hendriks, Tom, et al.
Publicado: (2017)

Contributions of Interactions Between Lifestyle and Genetics on Coronary Artery Disease Risk
por: Said, M. Abdullah, et al.
Publicado: (2019)

Development and first results of a dedicated chronic total occlusion programme
por: van der Werf, H. W., et al.
Publicado: (2019)

Pre-screening to guide coronary artery calcium scoring for early identification of high-risk individuals in the general population
por: Ties, Daan, et al.
Publicado: (2022)

Effect of metformin on outcome in patients undergoing primary percutaneous coronary intervention for st-segment elevation myocardial infarction
por: Posma, RA, et al.
Publicado: (2015)

Relationship of Arterial Stiffness Index and Pulse Pressure With Cardiovascular Disease and Mortality
por: Said, M. Abdullah, et al.
Publicado: (2018)

Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: A retrospective cohort study
por: Steenhuis, Dennis, et al.
Publicado: (2023)

The technology of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer’s Disease: A Retrospective Inception Cohort Study
por: Hutten, Danique R., et al.
Publicado: (2022)

Human genetic determinants of the gut microbiome and their associations with health and disease: a phenome-wide association study
por: Groot, Hilde E., et al.
Publicado: (2020)

Discontinuation and dose adjustment of metoprolol after metoprolol‐paroxetine/fluoxetine co‐prescription in Dutch elderly
por: Bahar, Muh. Akbar, et al.
Publicado: (2018)

Methylphenidate use and school performance among primary school children: a descriptive study
por: van der Schans, Jurjen, et al.
Publicado: (2017)

Fat pharms.
por: Ma, M
Publicado: (1996)

The Evolution of PharmVar
por: Gaedigk, Andrea, et al.
Publicado: (2018)

Legal problems of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

Genetics and the heart rate response to exercise
por: van de Vegte, Yordi J., et al.
Publicado: (2019)

Prehospital risk stratification in patients with chest pain
por: Sagel, Dennis, et al.
Publicado: (2021)

PharmGED: Pharmacogenetic Effect Database
por: Zheng, C. J., et al.
Publicado: (2007)

Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time?
por: Ties, Daan, et al.
Publicado: (2022)

Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial
por: Haver, Vincent G., et al.
Publicado: (2015)

Chronic ischemic mitral regurgitation and papillary muscle infarction detected by late gadolinium-enhanced cardiac magnetic resonance imaging in patients with ST-segment elevation myocardial infarction
por: Bouma, Wobbe, et al.
Publicado: (2016)

Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study
por: Leendertse, Anne J, et al.
Publicado: (2011)

ECOLOGY AND WILDLIFE: Pharmed Fish
por: Betts, Kellyn S.
Publicado: (2009)

Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction
por: Almesned, Mohammad A., et al.
Publicado: (2021)

Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction
por: Groot, Hilde E., et al.
Publicado: (2018)

Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial
por: Eppinga, Ruben N., et al.
Publicado: (2016)

Poor guideline adherence in the initiation of antidepressant treatment in children and adolescents in the Netherlands: choice of antidepressant and dose
por: de Vries, Ymkje Anna, et al.
Publicado: (2016)

Neurophysiological correlates of anhedonia in feedback processing
por: Mies, Gabry W., et al.
Publicado: (2013)

Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial
por: Posma, Rene A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k4the55mqo3muoirma34m8uun9